Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has updated its shareholders on the latest changes to its share capital and voting rights structure as of April 26, 2024. The company, a global leader in healthcare with a focus on defeating serious chronic diseases, maintains a strong presence in 80 countries and trades its shares on Nasdaq Copenhagen and the New York Stock Exchange. This announcement follows the company’s commitment to transparency in accordance with the Danish Capital Markets Act.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
